|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-2-7
|
|
pubmed:abstractText |
The prognosis of high-risk neuroblastoma patients has improved over the last decades. However, many patients experience relapse after successful initial treatment. We retrospectively analyzed the long-term outcome of relapsed patients of three consecutive national neuroblastoma trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
578-83
|
|
pubmed:meshHeading |
pubmed-meshheading:21298742-Adolescent,
pubmed-meshheading:21298742-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21298742-Child,
pubmed-meshheading:21298742-Child, Preschool,
pubmed-meshheading:21298742-Combined Modality Therapy,
pubmed-meshheading:21298742-Humans,
pubmed-meshheading:21298742-Infant,
pubmed-meshheading:21298742-Neoplasm Recurrence, Local,
pubmed-meshheading:21298742-Neuroblastoma,
pubmed-meshheading:21298742-Remission Induction,
pubmed-meshheading:21298742-Risk Factors,
pubmed-meshheading:21298742-Salvage Therapy,
pubmed-meshheading:21298742-Stem Cell Transplantation,
pubmed-meshheading:21298742-Survival Rate,
pubmed-meshheading:21298742-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials.
|
|
pubmed:affiliation |
Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, Cologne, Germany. thorsten.simon@uk-koeln.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
